このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

Generic Sweden バランスシートの健全性

財務の健全性基準チェック /66

Generic Swedenの総株主資本はSEK52.0M 、総負債はSEK0.0で、負債比率は0%となります。総資産と総負債はそれぞれSEK86.9MとSEK34.9Mです。 Generic Swedenの EBIT はSEK28.1Mで、利息カバレッジ比率-32.4です。現金および短期投資はSEK47.2Mです。

主要情報

負債資本比率

SEK 0

負債

インタレスト・カバレッジ・レシオ	-32.4x
現金	SEK 47.20m
エクイティ	SEK 51.99m
負債合計	SEK 34.91m
総資産	SEK 86.90m

財務の健全性に関する最新情報

更新なし

Recent updates

We Ran A Stock Scan For Earnings Growth And Generic Sweden (STO:GENI) Passed With Ease

Aug 26

A Look At The Intrinsic Value Of Generic Sweden AB (STO:GENI)

Apr 28

Is It Time To Consider Buying Generic Sweden AB (STO:GENI)?

Apr 08

Is Now The Time To Put Generic Sweden (STO:GENI) On Your Watchlist?

Feb 18

Calculating The Fair Value Of Generic Sweden AB (STO:GENI)

Jan 10

With EPS Growth And More, Generic Sweden (STO:GENI) Is Interesting

Nov 08

Here's Why I Think Generic Sweden (STO:GENI) Is An Interesting Stock

Jul 17

Here's Why I Think Generic Sweden (STO:GENI) Might Deserve Your Attention Today

Apr 13

Is Generic Sweden AB (STO:GENI) A Smart Pick For Income Investors?

Mar 26

A Look At The Intrinsic Value Of Generic Sweden AB (STO:GENI)

Mar 04

Should You Take Comfort From Insider Transactions At Generic Sweden AB (STO:GENI)?

Feb 14

Will Weakness in Generic Sweden AB's (STO:GENI) Stock Prove Temporary Given Strong Fundamentals?

Jan 26

Here's Why I Think Generic Sweden (STO:GENI) Might Deserve Your Attention Today

Jan 05

Is There More To The Story Than Generic Sweden's (STO:GENI) Earnings Growth?

Dec 16

Does Generic Sweden AB (STO:GENI) Have A Place In Your Dividend Portfolio?

Nov 25

財務状況分析

短期負債: GENIの短期資産 ( SEK79.7M ) が短期負債 ( SEK28.7M ) を超えています。

長期負債: GENIの短期資産 ( SEK79.7M ) が長期負債 ( SEK6.2M ) を上回っています。

デット・ツー・エクイティの歴史と分析

負債レベル: GENIは負債がありません。

負債の削減: GENI 5 年前には負債がありませんでした。

債務返済能力: GENIには負債がないため、営業キャッシュフローでカバーする必要はありません。

インタレストカバレッジ: GENIには負債がないため、利息支払いの負担は問題になりません。

Generic Sweden バランスシートの健全性

財務の健全性 基準チェック /66

主要情報

財務の健全性に関する最新情報

Recent updates

Now 20% undervalued

First quarter 2024 earnings: Revenues exceed analyst expectations

Now 23% undervalued

Upcoming dividend of kr1.50 per share

Now 23% undervalued after recent price drop

Some Confidence Is Lacking In Generic Sweden AB (STO:GENI) As Shares Slide 29%

Generic Sweden's (STO:GENI) Solid Earnings May Rest On Weak Foundations

Do Generic Sweden's (STO:GENI) Earnings Warrant Your Attention?

Full year 2023 earnings: EPS misses analyst expectations

Investor sentiment deteriorates as stock falls 16%

Now 25% undervalued

Should You Investigate Generic Sweden AB (STO:GENI) At kr60.20?

Investor sentiment improves as stock rises 16%

Now 22% undervalued

Third quarter 2023 earnings: Revenues exceed analyst expectations

Investor sentiment improves as stock rises 21%

Is Now The Time To Look At Buying Generic Sweden AB (STO:GENI)?

New major risk - Earnings quality

Investor sentiment improves as stock rises 17%

Should You Be Adding Generic Sweden (STO:GENI) To Your Watchlist Today?

Upcoming dividend of kr1.25 per share at 2.9% yield

Full year 2022 earnings: EPS exceeds analyst expectations

Investor sentiment improves as stock rises 21%

Full year 2022 earnings: EPS exceeds analyst expectations

Is Generic Sweden AB (STO:GENI) Potentially Undervalued?

Now 21% undervalued

Now 21% undervalued

Third quarter 2022 earnings: Revenues exceed analyst expectations

Investor sentiment improved over the past week

Second quarter 2022 earnings: Revenues miss analyst expectations

We Ran A Stock Scan For Earnings Growth And Generic Sweden (STO:GENI) Passed With Ease

Investor sentiment deteriorated over the past week

Now 23% undervalued after recent price drop

First quarter 2022 earnings: Revenues miss analyst expectations

Upcoming dividend of kr1.00 per share

A Look At The Intrinsic Value Of Generic Sweden AB (STO:GENI)

Less than half of directors are independent

Is It Time To Consider Buying Generic Sweden AB (STO:GENI)?

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Now 23% undervalued after recent price drop

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment deteriorated over the past week

Is Now The Time To Put Generic Sweden (STO:GENI) On Your Watchlist?

Investor sentiment improved over the past week

Calculating The Fair Value Of Generic Sweden AB (STO:GENI)

Investor sentiment deteriorated over the past week

Owner & Member of the board recently sold kr3.5m worth of stock

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Owner & Member of the board recently sold kr3.1m worth of stock

Third quarter 2021 earnings released

With EPS Growth And More, Generic Sweden (STO:GENI) Is Interesting

Investor sentiment deteriorated over the past week

Second quarter 2021 earnings released

Investor sentiment improved over the past week

Here's Why I Think Generic Sweden (STO:GENI) Is An Interesting Stock

Owner & Member of the board recently sold kr1.4m worth of stock

Owner & Member of the board recently sold kr1.3m worth of stock

Investor sentiment improved over the past week

First quarter 2021 earnings released

Upcoming dividend of kr0.80 per share

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Here's Why I Think Generic Sweden (STO:GENI) Might Deserve Your Attention Today

Is Generic Sweden AB (STO:GENI) A Smart Pick For Income Investors?

A Look At The Intrinsic Value Of Generic Sweden AB (STO:GENI)

Should You Take Comfort From Insider Transactions At Generic Sweden AB (STO:GENI)?

Will Weakness in Generic Sweden AB's (STO:GENI) Stock Prove Temporary Given Strong Fundamentals?

Here's Why I Think Generic Sweden (STO:GENI) Might Deserve Your Attention Today

Is There More To The Story Than Generic Sweden's (STO:GENI) Earnings Growth?

Market bids up stock over the past week

Does Generic Sweden AB (STO:GENI) Have A Place In Your Dividend Portfolio?

Market pulls back on stock over the past week

財務の健全性基準チェック /66